HomeComparePMXSF vs O

PMXSF vs O: Dividend Comparison 2026

PMXSF yields 7692.31% · O yields 5.28%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PMXSF wins by $4177739098279589.00M in total portfolio value
10 years
PMXSF
PMXSF
● Live price
7692.31%
Share price
$0.03
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4177739098279589.00M
Annual income
$4,073,565,928,588,968,500,000.00
Full PMXSF calculator →
O
Realty Income Corporation
● Live price
5.28%
Share price
$61.15
Annual div
$3.23
5Y div CAGR
15.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$34.2K
Annual income
$5,102.74
Full O calculator →

Portfolio growth — PMXSF vs O

📍 PMXSF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPMXSFO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PMXSF + O cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PMXSF pays
O pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PMXSF
Annual income on $10K today (after 15% tax)
$653,846.15/yr
After 10yr DRIP, annual income (after tax)
$3,462,531,039,300,623,000,000.00/yr
O
Annual income on $10K today (after 15% tax)
$449.12/yr
After 10yr DRIP, annual income (after tax)
$4,337.33/yr
At 15% tax rate, PMXSF beats the other by $3,462,531,039,300,623,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PMXSF + O for your $10,000?

PMXSF: 50%O: 50%
100% O50/50100% PMXSF
Portfolio after 10yr
$2088869549139794.50M
Annual income
$2,036,782,964,294,484,200,000.00/yr
Blended yield
97.51%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on O right now

PMXSF
No analyst data
O
Analyst Ratings
13
Buy
18
Hold
3
Sell
Consensus: Hold
Price Target
$64.00
+4.7% upside vs current
Range: $60.00 — $69.00
Altman Z
1.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PMXSF buys
0
O buys
0
No recent congressional trades found for PMXSF or O in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPMXSFO
Forward yield7692.31%5.28%
Annual dividend / share$2.00$3.23
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.1%
Portfolio after 10y$4177739098279589.00M$34.2K
Annual income after 10y$4,073,565,928,588,968,500,000.00$5,102.74
Total dividends collected$4170772265337663.00M$20.7K
Payment frequencyquarterlymonthly
SectorStockREIT

Year-by-year: PMXSF vs O ($10,000, DRIP)

YearPMXSF PortfolioPMXSF Income/yrO PortfolioO Income/yrGap
1← crossover$779,931$769,230.77$10,818$608.16+$769.1KPMXSF
2$56,904,315$56,069,789.30$11,787$741.68+$56.89MPMXSF
3$3,884,151,673$3,823,264,055.84$12,946$911.00+$3884.14MPMXSF
4$248,050,254,929$243,894,212,638.74$14,345$1,127.94+$248050.24MPMXSF
5$14,822,056,221,428$14,556,642,448,653.80$16,056$1,409.05+$14822056.21MPMXSF
6$828,776,618,419,079$812,917,018,262,150.50$18,171$1,777.83+$828776618.40MPMXSF
7$43,367,472,132,823,630$42,480,681,151,115,220.00$20,820$2,268.21+$43367472132.80MPMXSF
8$2,123,871,047,251,591,000$2,077,467,852,069,469,400.00$24,188$2,929.90+$2123871047251.57MPMXSF
9$97,358,102,514,598,310,000$95,085,560,494,039,100,000.00$28,533$3,837.11+$97358102514598.28MPMXSF
10$4,177,739,098,279,589,000,000$4,073,565,928,588,968,500,000.00$34,235$5,102.74+$4177739098279589.00MPMXSF

PMXSF vs O: Complete Analysis 2026

PMXSFStock

Pharmaxis Ltd engages in the research, development, and commercialization of healthcare products for the treatment of fibrotic and inflammatory diseases worldwide. The company operates through two segments, Mannitol Respiratory Business and New Drug Development. It offers Bronchitol, an inhaled dry powder for the treatment of cystic fibrosis; and Aridol, an airways inflammation test that is used to identify twitchy or hyper-responsive airways, as well as to assist in diagnosing and managing asthma. The company's product pipeline consists of oral pan-lysyl oxidase inhibitors (LOX) targeting myelofibrosis and other cancers; topical pan-LOX inhibitors targeting skin scarring after events, such as accidents, surgery,and burns; selective Lysyl Oxidase Like Inhibitors (LOXL2) targeting chronic fibrotic diseases, including kidney fibrosis, pulmonary fibrosis, liver fibrosis, and cardiac fibrosis; and semicarbazide-sensitive amine oxidase for neuro inflammatory diseases. It is also developing Orbital, a dry powder inhaler to deliver high drug doses to lungs. Pharmaxis Ltd was incorporated in 1998 and is headquartered in Frenchs Forest, Australia.

Full PMXSF Calculator →

OREIT

Realty Income, The Monthly Dividend Company, is an S&P 500 company dedicated to providing stockholders with dependable monthly income. The company is structured as a REIT, and its monthly dividends are supported by the cash flow from over 6,500 real estate properties owned under long-term lease agreements with our commercial clients. To date, the company has declared 608 consecutive common stock monthly dividends throughout its 52-year operating history and increased the dividend 109 times since Realty Income's public listing in 1994 (NYSE: O). The company is a member of the S&P 500 Dividend Aristocrats index. Additional information about the company can be obtained from the corporate website at www.realtyincome.com.

Full O Calculator →
📬

Get this PMXSF vs O comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PMXSF vs SCHDPMXSF vs JEPIPMXSF vs KOPMXSF vs MAINPMXSF vs STAGPMXSF vs ADCPMXSF vs NNNPMXSF vs VICI

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.